Niklas LindegardhGeraint R. DaviesTinh Hien TranJeremy FarrarPratap SinghasivanonNicholas P J DayNicholas J. WhiteMahidol UniversityNuffield Department of Clinical MedicineUniversity of LiverpoolUCL2018-08-242018-08-242007-05-01Antimicrobial Agents and Chemotherapy. Vol.51, No.5 (2007), 1835-1836006648042-s2.0-34248381197https://repository.li.mahidol.ac.th/handle/20.500.14594/24916Ex vivo conversion of the anti-influenza drug oseltamivir to its active metabolite can be inhibited by the esterase inhibitor dichlorvos or by using commercial fluoride-oxalate tubes. Oseltamivir and its active metabolite remain intact in plasma samples during a proposed virus heat inactivation step: incubation at 60°C for 45 min. Copyright © 2007, American Society for Microbiology. All Rights Reserved.Mahidol UniversityMedicineArticleSCOPUS10.1128/AAC.01534-06